Mars announces plans to invest $1.4 billion in U.S. manufacturing, operations in 2027
Mars Inc. announced Tuesday that it plans to invest an estimated $1.4 billion in its U.S. manufacturing facilities and operations in 2027, marking the company’s largest investment in a single year.
The announcement, made Nov. 10, builds on more than $9 billion Mars has invested in its domestic operations since 2017.
The company, which produces popular brands including M&M’S, Snickers, Cheez-It, Ben’s Original, Pedigree and Royal Canin, said the investment will support manufacturing expansion, modernization, innovation and veterinary services across the country.
“As Mars marks 115 years in business, our commitment to American manufacturing has never been stronger,” said Claus Aagaard, CFO of Mars, Incorporated. “Ninety-four percent of the Mars products sold in the U.S. are made here, reflecting decades of investment in our people, operations and the communities in which we do business. Our continued investments build for the future – expanding our manufacturing capabilities, accelerating growth across our portfolio and services and ensuring we can meet the evolving needs of consumers for generations to come.”
As part of the planned investment, Mars will spend more than $34 million in early 2027 to open four veterinary hospitals across the United States.
The new facilities will include three BluePearl Pet Hospitals in Ellicott City, Maryland; Austin, Texas; and Katy, Texas, along with a Banfield Pet Hospital in Wilmington, North Carolina.
According to the company, the hospitals will expand access to emergency and specialty veterinary care, introduce advanced medical capabilities and create up to 195 jobs.
Mars said the broader investment strategy is intended to expand production capacity, modernize existing facilities and strengthen its supply chain while supporting growth across its snacking, food and pet care businesses.
The company also highlighted several major investments made in 2026.
In Salt Lake City, Utah, Mars invested $60 million to add two manufacturing lines for its Trü Frü brand at a $240 million facility that opened in 2025 to produce Nature’s Bakery products.
The expansion will allow the facility to manufacture approximately 17 million Trü Frü frozen products annually, in addition to its existing capacity to produce more than 1 billion Nature’s Bakery snack bars each year.
In Waco, Texas, Mars is marking the 50th anniversary of its manufacturing facility, where the company has invested $165 million since 2024.
The facility produces more than 56 billion pieces of Snickers, Starburst and Skittles candy annually. Recent investments have focused on improving energy efficiency, modernizing operations and supporting new product development, including Snickers Xtreme Almond and Starburst Sour products.
Mars also announced a $49 million investment in its wet pet food manufacturing facility in Columbus, Ohio, to bring production of Temptations Lickable Treats to the United States.
The project includes new mixing and filling technology and will provide capacity to produce more than 400 million treat pouches annually.
The company said it has invested a total of $162 million in the Columbus facility since 2022.
Mars, which is headquartered in the United States, employs approximately 80,000 people nationwide. Its domestic operations include more than 60 factories, research laboratories and offices, along with more than 2,000 veterinary clinics and hospitals.
The company also added 15 facilities to its U.S. operations over the past year through its acquisition of Kellanova.
Mars said it plans to continue investing in manufacturing modernization and operational improvements across its expanded U.S. portfolio as part of its long-term growth strategy.
